115 related articles for article (PubMed ID: 19532027)
1. Discriminate use of antibiotics for exacerbation of COPD.
Stolz D; Tamm M
Curr Opin Pulm Med; 2009 Mar; 15(2):126-32. PubMed ID: 19532027
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin as a prognostic factor in severe acute exacerbation of chronic obstructive pulmonary disease.
Rammaert B; Verdier N; Cavestri B; Nseir S
Respirology; 2009 Sep; 14(7):969-74. PubMed ID: 19659517
[TBL] [Abstract][Full Text] [Related]
4. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD.
Stolz D; Christ-Crain M; Morgenthaler NG; Leuppi J; Miedinger D; Bingisser R; Müller C; Struck J; Müller B; Tamm M
Chest; 2007 Apr; 131(4):1058-67. PubMed ID: 17426210
[TBL] [Abstract][Full Text] [Related]
5. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD.
Soler N; Esperatti M; Ewig S; Huerta A; Agustí C; Torres A
Eur Respir J; 2012 Dec; 40(6):1344-53. PubMed ID: 22523352
[TBL] [Abstract][Full Text] [Related]
6. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin-guided antibiotic therapy for chronic obstructive pulmonary disease exacerbations.
Tokman S; Schuetz P; Bent S
Expert Rev Anti Infect Ther; 2011 Jun; 9(6):727-35. PubMed ID: 21692680
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
Daubin C; Parienti JJ; Vabret A; Ramakers M; Fradin S; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
BMC Infect Dis; 2008 Oct; 8():145. PubMed ID: 18947382
[TBL] [Abstract][Full Text] [Related]
9. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1: use of a procalcitonin algorithm to guide antimicrobial therapy in COPD exacerbations can reduce antibiotic consumption with no increase in rates of treatment failure or mortality.
Hankey B; Riley B
Emerg Med J; 2015 Jun; 32(6):493-5. PubMed ID: 25991774
[TBL] [Abstract][Full Text] [Related]
10. Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial.
Wang JX; Zhang SM; Li XH; Zhang Y; Xu ZY; Cao B
Int J Infect Dis; 2016 Jul; 48():40-5. PubMed ID: 27155210
[TBL] [Abstract][Full Text] [Related]
11. [Not all exacerbations of chronic obstructive pulmonary disease should be treated with antibiotics].
Nielsen SK; Lange P
Ugeskr Laeger; 2017 Apr; 179(15):. PubMed ID: 29332624
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin-guided antibiotic therapy in COPD exacerbations: closer but not quite there.
Martinez FJ; Curtis JL
Chest; 2007 Jan; 131(1):1-2. PubMed ID: 17218546
[No Abstract] [Full Text] [Related]
13. Factors predicting bacterial involvement in severe acute exacerbations of chronic obstructive pulmonary disease.
Nseir S; Cavestri B; Di Pompeo C; Diarra M; Brisson H; Lemyze M; Roussel-Delvallez M; Durocher A
Respiration; 2008; 76(3):253-60. PubMed ID: 18547944
[TBL] [Abstract][Full Text] [Related]
14. Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia.
Perren A; Cerutti B; Lepori M; Senn V; Capelli B; Duchini F; Domenighetti G
Infection; 2008 Mar; 36(2):163-6. PubMed ID: 18330505
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia.
Justo D; Lachmi S; Saar N; Joffe E; Atzmony L; Mashav N; Henis O; Sade B; Chundadze T; Steinvil A; Paran Y
Eur J Intern Med; 2009 Sep; 20(5):518-21. PubMed ID: 19712857
[TBL] [Abstract][Full Text] [Related]
16. [The changes and clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease].
Chang C; Yao WZ; Chen YH; Liu ZY; Zhang XW
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jul; 29(7):444-7. PubMed ID: 17045042
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics for acute and chronic respiratory infection in patients with chronic obstructive pulmonary disease.
Miravitlles M; Anzueto A
Am J Respir Crit Care Med; 2013 Nov; 188(9):1052-7. PubMed ID: 23924286
[TBL] [Abstract][Full Text] [Related]
18. Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count.
Casado-Flores J; Blanco-Quirós A; Asensio J; Arranz E; Garrote JA; Nieto M
Pediatr Crit Care Med; 2003 Apr; 4(2):190-5. PubMed ID: 12749651
[TBL] [Abstract][Full Text] [Related]
19. Metallic elements in exhaled breath condensate and serum of patients with exacerbation of chronic obstructive pulmonary disease.
Corradi M; Acampa O; Goldoni M; Andreoli R; Milton D; Sama SR; Rosiello R; de Palma G; Apostoli P; Mutti A
Metallomics; 2009; 1(4):339-45. PubMed ID: 21305131
[TBL] [Abstract][Full Text] [Related]
20. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
